Qualigen Therapeutics (QLGN) Institutional Ownership → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free QLGN Stock Alerts $0.30 -0.01 (-3.40%) (As of 05:18 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Qualigen Therapeutics (NASDAQ:QLGN)CurrentInstitutional OwnershipPercentage3.18%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$49.73KNumber ofInstitutional Sellers(last 12 months)0 Get QLGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Qualigen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QLGN Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. Qualigen Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/10/2023 Meitav Investment House Ltd.27,293$3.21M0.0%N/A0.540% 7/24/2023 Meitav Investment House Ltd.27,293$3.21M0.1%N/A0.540% 5/10/2022 Ground Swell Capital LLC43,251$29K0.1%N/A0.123% 1/31/2022Commonwealth Equity Services LLC87,510$93K0.0%-36.4%0.298% 11/15/2021 Franklin Resources Inc.82,000$107K0.0%N/A0.283% 11/15/2021 GSA Capital Partners LLP78,687$102K0.0%N/A0.271% Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/14/2021Hatton Consulting Inc.27,195$35K0.0%-26.9%0.094% 8/16/2021State Street Corp104,314$208K0.0%N/A0.362% 8/13/2021 Renaissance Technologies LLC113,911$227K0.0%N/A0.395% 8/13/2021 Geode Capital Management LLC168,702$335K0.0%+10.3%0.585% 8/13/2021 Vanguard Group Inc.1,023,911$2.04M0.0%+239.9%3.551% 8/11/2021Commonwealth Equity Services LLC137,510$273K0.0%+10.9%0.477% 8/2/2021Hatton Consulting Inc.37,195$74K0.1%-35.0%0.129% 6/23/2021 StoneX Group Inc.13,442$36K0.0%N/A0.047% 5/17/2021Price T Rowe Associates Inc. MD107,500$290K0.0%N/A0.373% 5/12/2021 Geode Capital Management LLC152,898$412K0.0%+24.3%0.530% 5/11/2021 Vontobel Holding Ltd.25,300$68K0.0%N/A0.088% 5/10/2021 GSA Capital Partners LLP18,031$49K0.0%N/A0.063% 5/5/2021Hatton Consulting Inc.57,195$154K0.1%N/A0.198% 5/4/2021Commonwealth Equity Services LLC124,049$334K0.0%+716.3%0.538% 4/28/2021 Perkins Capital Management Inc.31,652$85K0.0%N/A0.137% 4/22/2021 HighMark Wealth Management LLC80,094$216K0.2%N/A0.347% 2/17/2021Cetera Investment Advisers40,275$121K0.0%+140.2%0.175% 2/11/2021 Northern Trust Corp38,731$117K0.0%N/A0.168% 2/10/2021QS Investors LLC82,000$247K0.0%N/A0.356% 2/9/2021 Wells Fargo & Company MN30,577$92K0.0%+19,010.6%0.133% 2/9/2021 Bank of New York Mellon Corp20,824$63K0.0%N/A0.090% 2/5/2021 BlackRock Inc.317,818$957K0.0%+1.2%1.378% 2/5/2021 US Bancorp DE9,851$29K0.0%N/A0.043% 1/27/2021 CRA Financial Services LLC19,957$60K0.0%N/A0.087% 11/13/2020Cetera Investment Advisers16,765$83K0.0%N/A0.080% 11/12/2020 JPMorgan Chase & Co.5,600$27K0.0%N/A0.027% 11/6/2020 BlackRock Inc.314,126$1.56M0.0%+54,247.1%1.494% 8/17/2020Jane Street Group LLC10,783$43K0.0%N/A0.056% 8/7/2020Virtu Financial LLC29,887$119K0.0%N/A0.155% (Data available from 1/1/2016 forward) QLGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QLGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Qualigen Therapeutics shares: Meitav Investment House Ltd. ($3.21M).Learn more on QLGN's institutional investors. What percentage of Qualigen Therapeutics stock is owned by institutional investors? 3.18% of Qualigen Therapeutics stock is owned by institutional investors. Learn more on QLGN's institutional investor holdings. Which institutional investors have been buying Qualigen Therapeutics stock? The following institutional investors have purchased Qualigen Therapeutics stock in the last 24 months: Meitav Investment House Ltd. ($54.59K). How much institutional buying is happening at Qualigen Therapeutics? Institutional investors have bought a total of 54,586 shares in the last 24 months. This purchase volume represents approximately $49.73K in transactions. Related Companies: ALLR Institutional Ownership PRFX Institutional Ownership ATNF Institutional Ownership INM Institutional Ownership CMND Institutional Ownership GLMD Institutional Ownership NBSE Institutional Ownership DRMA Institutional Ownership LSDI Institutional Ownership PBLA Institutional Ownership This page (NASDAQ:QLGN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.